Emerging research about autoantibodies in type 1 diabetes is redefining the natural history of this disease, and could lead to new diagnostic criteria.
In 2014, the federal government will ramp up the pressure on providers to embrace electronic health records with the second stage of meaningful use guidelines, requiring providers to meet tough new standards or face payment cuts.
FDA regulation of laboratory-developed tests could limit the availability of flow cytometry assays, since they cannot be validated using standard methods. In light of this, international experts in the field of flow cytometry have published guidelines that address the differences between validating flow cytometric tests and traditional clinical chemistry assays.
The American College of Physicians recently recommended against regular screening for chronic kidney disease in asymptomatic adults without risk factors, but the American Society of Nephrology maintains that regular screening is vital to stemming the U.S. kidney disease epidemic.
The American Society of Clinical Oncology and College of American Pathologists have updated their guideline on human epidermal growth factor receptor 2 testing in breast cancer. The new document includes recommendations for bright-field in-situ hybridization, as well as refined optimal testing algorithms and revised optimal test validation requirements.
In a free AACC webcast, AACC Past President Greg Miller, PhD, explains the current status of harmonization for clinical lab tests, as well as how leaders in laboratory medicine plan to tackle the formidable challenges of making different kinds of lab tests for the same analyte agree.
Download the entire issue
Chronic Kidney Disease: The Search for Better Biomarkers Preimplantation Genetic Diagnosis